Literature DB >> 20484397

Susceptibility pathways in Fanconi's anemia and breast cancer.

Alan D D'Andrea1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20484397      PMCID： PMC3069698          DOI： 10.1056/NEJMra0809889

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  117 in total

Review 1.  The Fanconi anemia/BRCA pathway: a coordinator of cross-link repair.

Authors:  Kanchan D Mirchandani; Alan D D'Andrea
Journal:  Exp Cell Res       Date:  2006-06-21       Impact factor: 3.905

2.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

3.  Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.

Authors:  Alberto Ciccia; Chen Ling; Rachel Coulthard; Zhijiang Yan; Yutong Xue; Amom Ruhikanta Meetei; El Houari Laghmani; Hans Joenje; Neil McDonald; Johan P de Winter; Weidong Wang; Stephen C West
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

Review 4.  Fanconi anemia.

Authors:  Grover C Bagby; Blanche P Alter
Journal:  Semin Hematol       Date:  2006-07       Impact factor: 3.851

5.  Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.

Authors:  John E Wagner; Jakub Tolar; Orna Levran; Thomas Scholl; Amie Deffenbaugh; Jaya Satagopan; Leah Ben-Porat; Katherine Mah; Sat Dev Batish; David I Kutler; Margaret L MacMillan; Helmut Hanenberg; Arleen D Auerbach
Journal:  Blood       Date:  2004-01-08       Impact factor: 22.113

6.  Interaction of FANCD2 and NBS1 in the DNA damage response.

Authors:  Koji Nakanishi; Toshiyasu Taniguchi; Velvizhi Ranganathan; Helen V New; Lisa A Moreau; Maria Stotsky; Christopher G Mathew; Michael B Kastan; David T Weaver; Alan D D'Andrea
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

7.  Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer.

Authors:  Gopeshwar Narayan; Hugo Arias-Pulido; Subhadra V Nandula; Katia Basso; Dorcas D Sugirtharaj; Hernan Vargas; Mahesh Mansukhani; Jeannine Villella; Larissa Meyer; Achim Schneider; Lutz Gissmann; Matthias Dürst; Bhavana Pothuri; Vundavalli V V S Murty
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 8.  The Fanconi anaemia/BRCA pathway.

Authors:  Alan D D'Andrea; Markus Grompe
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

9.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.

Authors:  Sarah Reid; Detlev Schindler; Helmut Hanenberg; Karen Barker; Sandra Hanks; Reinhard Kalb; Kornelia Neveling; Patrick Kelly; Sheila Seal; Marcel Freund; Melanie Wurm; Sat Dev Batish; Francis P Lach; Sevgi Yetgin; Heidemarie Neitzel; Hany Ariffin; Marc Tischkowitz; Christopher G Mathew; Arleen D Auerbach; Nazneen Rahman
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

10.  Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.

Authors:  Nuala McCabe; Nicholas C Turner; Christopher J Lord; Katarzyna Kluzek; Aneta Bialkowska; Sally Swift; Sabrina Giavara; Mark J O'Connor; Andrew N Tutt; Małgorzata Z Zdzienicka; Graeme C M Smith; Alan Ashworth
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701
View more
  156 in total

1.  GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.

Authors:  Mark E Bernard; Hyun Kim; Hebist Berhane; Michael W Epperly; Darcy Franicola; Xichen Zhang; Frank Houghton; Donna Shields; Hong Wang; Christopher J Bakkenist; Marie-Celine Frantz; Erin M Forbeck; Julie P Goff; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2011-09-22       Impact factor: 2.841

2.  Novel germline PALB2 truncating mutations in African American breast cancer patients.

Authors:  Yonglan Zheng; Jing Zhang; Qun Niu; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

3.  Gene therapy for Fanconi anemia: one step closer to the clinic.

Authors:  Jakub Tolar; Pamela S Becker; D Wade Clapp; Helmut Hanenberg; Cristina Díaz de Heredia; Hans-Peter Kiem; Susana Navarro; Pankaj Qasba; Paula Rio; Manfred Schmidt; Julián Sevilla; Els Verhoeyen; Adrian J Thrasher; Juan Bueren
Journal:  Hum Gene Ther       Date:  2012-02       Impact factor: 5.695

4.  Impaired function of Fanconi anemia type C-deficient macrophages.

Authors:  Ying Liu; Kimberly Ballman; Deqiang Li; Shehnaz Khan; Ethel Derr-Yellin; Weinian Shou; Laura S Haneline
Journal:  J Leukoc Biol       Date:  2011-11-21       Impact factor: 4.962

Review 5.  Regulation of DNA cross-link repair by the Fanconi anemia/BRCA pathway.

Authors:  Hyungjin Kim; Alan D D'Andrea
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

6.  Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.

Authors:  Raphael Ceccaldi; Delphine Briot; Jérôme Larghero; Nadia Vasquez; Catherine Dubois d'Enghien; Delphine Chamousset; Maria-Elena Noguera; Quinten Waisfisz; Olivier Hermine; Corinne Pondarre; Thierry Leblanc; Eliane Gluckman; Hans Joenje; Dominique Stoppa-Lyonnet; Gérard Socié; Jean Soulier
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

7.  Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.

Authors:  Tom Walsh; Silvia Casadei; Ming K Lee; Christopher C Pennil; Alex S Nord; Anne M Thornton; Wendy Roeb; Kathy J Agnew; Sunday M Stray; Anneka Wickramanayake; Barbara Norquist; Kathryn P Pennington; Rochelle L Garcia; Mary-Claire King; Elizabeth M Swisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

8.  Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair.

Authors:  Luca Colnaghi; Mathew J K Jones; Xiomaris M Cotto-Rios; Detlev Schindler; Helmut Hanenberg; Tony T Huang
Journal:  Blood       Date:  2010-10-22       Impact factor: 22.113

9.  Human exonuclease 5 is a novel sliding exonuclease required for genome stability.

Authors:  Justin L Sparks; Rakesh Kumar; Mayank Singh; Marc S Wold; Tej K Pandita; Peter M Burgers
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

10.  CtIP mediates replication fork recovery in a FANCD2-regulated manner.

Authors:  Jung Eun Yeo; Eu Han Lee; Eric A Hendrickson; Alexandra Sobeck
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.